APPLICATION
ANDA076499
TYPE
ANDA
ORIGINAL APPROVAL
2007-11-21
LATEST ACTION
2020-12-10
ROUTE
TOPICAL
DOSAGE FORM
LOTION
MARKETING STATUS
Prescription
Products
MOMETASONE FUROATEPrescription
MOMETASONE FUROATE 0.1% · LOTION · TOPICAL
Approval history
2020-12-10Labeling · Supplement 15 · standardAP
2015-10-26Labeling · Supplement 10 · standardAP
2012-11-30Labeling · Supplement 9 · standardAP
2007-11-21OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.